GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CBAN · Mar 31, 2025

COLONY BANKCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000711669-25-000067Bank
Sequential deposit growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

2.13% · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

24.00% · CORE · VALID

Interest-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

6.65% · CORE · VALID

Cash and equivalents95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$221.2M · CORE · VALID

Sequential loan growth75thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

4.24% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History60 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
1.70%
Current
2.13%
Delta
0.42%
Earnings Growth Increased
Previous
9.75%
Current
24.00%
Delta
14.25%
Interest Income Growth Decreased
Previous
9.87%
Current
6.65%
Delta
-3.22%
Liquidity Decreased
Previous
$231.0M
Current
$221.2M
Delta
-$9.8M
Loan Growth Increased
Previous
-2.27%
Current
4.24%
Delta
6.51%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.